The oncologist
Enhanced efficacy and long-term survival with SBRT plus PD-1 inhibitors versus SBRT alone in unresectable HCC: a multicenter PSM study.
Xubiao Wei, Yabo Jiang, Yong Li, Hong Shi, Weixing Guo, Jie Shi, Zhaochong Zeng, Tianfu Wen, Yang Jiao, Miaomiao Wang, Shuqun Cheng
Published: 202610.1093/oncolo/oyaf437
Abstract
BACKGROUND: Radiotherapy (RT) provides meaningful local control for hepatocellular carcinoma (HCC) but is limited by radio-resistance. Preclinical and clinical data suggest that adding programmed death receptor-1 (PD-1) blockade may enhance radiosens…
Preview only. Read the full abstract at the source